Wolfgang Janni

发表

Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

Brigitte Rack, Thomas Rau, Massimo Cristofanilli, 2007, Clinical Cancer Research.

Abstract PD1-02: Cancer predisposition genes in metastatic breast cancer – Association with metastatic pattern, prognosis, patient and tumor characteristics

Steven N. Hart, Chunling Hu, Peter A. Fasching, 2018 .

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Michael Jones, Peter Kraft, Arnaud Droit, 2017, Nature Genetics.

Exploring patient- and physician-related factors preventing breast cancer patients from guideline-adherent adjuvant chemotherapy—results from the prospective multi-center study BRENDA II

Maria Blettner, Lukas Schwentner, Susanne Singer, 2016, Supportive Care in Cancer.

Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer

Brigitte Rack, Klaus Pantel, K. Pantel, 2010, Breast Cancer Research.

Use of circulating tumor cells (CTC) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy to predict risk for relapse: The SUCCESS trial.

Brigitte Rack, Matthias W. Beckmann, Andreas Schneeweiss, 2010 .

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

Mike Clarke, Yasuo Ohashi, Michael Gnant, 2018, The Lancet. Oncology.

Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen

Brigitte Rack, Uwe Karsten, Harald Sommer, 2008, Clinical & Experimental Metastasis.

Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression

Brigitte Rack, Sabine Kasimir-Bauer, Klaus Pantel, 2011, BMC Cancer.

The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study

Nina Ditsch, Michael Golatta, Alfons Meindl, 2012, Breast Cancer Research.

Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.

Brigitte Rack, Seth Slettedahl, Heli Nevanlinna, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Side Effects of Standard Adjuvant and Neoadjuvant Chemotherapy Regimens According to Age Groups in Primary Breast Cancer

Nadia Harbeck, S. Loibl, N. Harbeck, 2013, Breast Care.

The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer

Tanja Fehm, Brigitte Rack, Peter A Fasching, 2018, Breast Cancer Research and Treatment.

Guidelines are advantageous, though not essential for improved survival among breast cancer patients

Maria Blettner, Igor Novopashenny, Lukas Schwentner, 2015, Breast Cancer Research and Treatment.

Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

Tanja Fehm, Brigitte Rack, Matthias W. Beckmann, 2014, Journal of the National Cancer Institute.

Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial.

Brigitte Rack, Christos Sotiriou, Sabine Riethdorf, 2016, European journal of cancer.